Axsome Therapeutics (AXSM) has a market capitalization of $11.6B, based on 51.04M shares at a price of $226.75 (up 0.2% yesterday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
May 2026 | $226.67 | 11,413,166 | 51,040,904 | $11,569,441,709.68 |
April 2026 | $207.75 | 15,066,300 | 51,040,904 | $10,603,747,806.00 |
March 2026 | $169.02 | 12,671,767 | 51,198,300 | $8,653,536,666.00 |
February 2026 | $163.89 | 11,872,800 | 51,198,300 | $8,390,889,387.00 |
January 2026 | $184.25 | 15,344,977 | 51,198,300 | $9,433,286,775.00 |
December 2025 | $182.64 | 13,332,699 | 50,631,300 | $9,247,300,632.00 |
November 2025 | $151.50 | 11,396,400 | 50,631,300 | $7,670,641,950.00 |
October 2025 | $134.99 | 10,640,400 | 50,631,300 | $6,834,719,187.00 |
September 2025 | $121.45 | 11,489,000 | 50,021,900 | $6,075,159,755.00 |
August 2025 | $121.28 | 12,084,000 | 50,021,900 | $6,066,656,032.00 |
July 2025 | $101.38 | 13,841,700 | 50,021,900 | $5,071,220,222.00 |
June 2025 | $104.39 | 14,394,000 | 49,442,000 | $5,161,250,380.00 |
May 2025 | $105.16 | 12,666,900 | 49,442,000 | $5,199,320,720.00 |
April 2025 | $112.29 | 18,661,100 | 49,442,000 | $5,551,842,180.00 |
March 2025 | $116.63 | 12,428,400 | 48,871,200 | $5,699,848,056.00 |
February 2025 | $127.54 | 22,348,600 | 48,871,200 | $6,233,032,848.00 |
January 2025 | $106.46 | 19,793,800 | 48,871,200 | $5,202,827,952.00 |
December 2024 | $84.61 | 14,298,700 | 48,541,900 | $4,107,130,159.00 |
November 2024 | $98.22 | 12,088,200 | 48,541,900 | $4,767,785,418.00 |
October 2024 | $89.03 | 9,462,100 | 48,541,900 | $4,321,685,357.00 |
September 2024 | $89.87 | 9,087,300 | 48,140,500 | $4,326,386,735.00 |
August 2024 | $88.86 | 9,424,100 | 48,140,500 | $4,277,764,830.00 |
July 2024 | $87.31 | 13,181,600 | 48,140,500 | $4,203,147,055.00 |
June 2024 | $80.50 | 17,676,900 | 47,573,200 | $3,829,642,600.00 |
May 2024 | $73.43 | 12,689,200 | 47,573,200 | $3,493,300,076.00 |